News and Educations

Information about the recall of one batch of the medicinal product Parfalgan 10 mg/ml solution for infusion


The company PharmaSwiss d.o.o., the marketing authorisation holder for the medicinal product Perfalgan 10 mg/ml solution for infusion, is recalling , upon HALMED’s request, the batch 2A74306, of the medicinal product Perfalgan 10 mg/ml, solution for infusion. The decision has been taken following a quality defect report due to a change in the colour of the solution for infusion.

The marketing authorisation holder has informed all their wholesalers and hospital pharmacies about the recall.

We remind healthcare professionals that they should report any adverse reaction to HALMED, as well as quality defect. Patients who have developed any adverse reaction to medicinal product may report it directly to HALMED via form or on-line application, with recommendation regarding any adverse reaction they discover to consult with their doctor or pharmacist about the continuation of their therapy.